Carlisle Companies Inc. (CSL)

Trade CSL now with
10/18/2021 9:58:57 PM CSL Says Advances Novel Pipeline Spanning Six Therapeutic Areas, Four Scientific Platforms And Two Businesses
10/4/2021 8:04:37 AM Seqirus Receives Multi-year, $34.95 Mln U.S. Govt. Contract To Develop Two Pandemic Influenza Vaccines
9/9/2021 8:36:20 AM CSL's Global Chief Human Resources Officer Elizabeth Walker Appointed To Urban League Of Philadelphia's Board
9/1/2021 4:09:19 PM Carlisle Companies Completes Purchase Of Henry Company
8/26/2021 8:08:32 AM CSL Plasma To Provide Influenza Vaccination Vouchers To U.S. Plasma Donors
8/19/2021 8:32:38 AM Seqirus Plans To Accelerate Development Of Next Generation Of Messenger RNA Vaccine Technology
8/3/2021 9:13:00 AM CSL Behring : FDA Approves New BERINERT Administration Kit For Increased Patient Convenience
8/2/2021 4:14:39 PM Carlisle Companies Completes Sale Of Carlisle Brake & Friction
8/2/2021 4:14:22 PM CentroMotion Completes Acquisition Of Carlisle Brake & Friction
7/30/2021 8:32:38 AM Seqirus Presents New Safety Data Demonstrating Safety Of Cell-Based Seasonal Influenza Vaccine On Pregnancy Outcomes
7/22/2021 4:12:45 PM Carlisle Reports Q2 EPS Of $1.87 Vs. $1.36 Last Year
7/19/2021 6:46:47 AM Carlisle To Buy Henry For $1.575 Bln Cash
6/8/2021 9:31:46 AM CSL Behring : Hizentra To Be Covered Under Same Medicare Benefit Category As Intravenous Immune Globulin
5/25/2021 8:48:36 AM Carlisle Companies To Sell Carlisle Brake & Friction To CentroMotion Of Waukesha, Wisconsin
5/3/2021 9:41:09 AM Seqirus Presents Phase3 Data Supporting Use Of Cell-Based Seasonal Influenza Vaccine In Children 6-Months Through <4 Yrs